Sign in
MBOT Stock Price, Chart, Stats & News
Microbot Medical Inc.
Save
Microbot Medical Inc. (MBOT) does not currently pay a dividend.
63.81M
Market cap
–
Current P/E
31.75x
Forward P/E
MBOT chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -16.12% |
ROE | -24.44% |
D/E | 0.01x |
Interest coverage ratio | – |
MBOT valuation
P/E | – |
P/S | – |
P/B | 2.07x |
P/CF | -12.30x |
P/FCF | -8.31x |
P/OCF | -12.30x |
PEG | -0.31x |
EV multiple | -7.89x |
About
Microbot Medical Inc. operates as a pre-clinical stage medical device company, concentrating its efforts on the research, design, and development of robotic instruments for endoluminal surgery, specifically targeting the field of minimally invasive procedures. Leveraging its proprietary micro-robotic technologies, which include ViRob, TipCAT, CardioSert, and Liberty, the company is actively developing several key products. These include a Self-Cleaning Shunt intended for the treatment of hydrocephalus and normal pressure hydrocephalus, as well as a single-use robotic system designed for various endovascular interventional applications.
Similar securities
Based on sector and market capitalization
Report issue